NCT03824002View on ClinicalTrials.gov

Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables

PHASE4CompletedINTERVENTIONAL
Enrollment

92

Participants

Timeline

Start Date

April 1, 2017

Primary Completion Date

October 1, 2017

Study Completion Date

April 20, 2018

Conditions
Diabetes Mellitus
Interventions
DRUG

Dulaglutide

Diabetes therapy with dulaglutide and various combinations of insulin, metformin, glinides

DRUG

Aspart insulin

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Glargine

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Metformin

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

DRUG

Repaglinide

Diabetes therapy with various combinations of insulin, metformin, glinides but without dulaglutide

Trial Locations (1)

90127

Internal Medicine Ward, University of Palermo, Palermo

All Listed Sponsors
lead

University of Palermo

OTHER

NCT03824002 - Dulaglutide in Diabetic Patients, Relationship Between Arterial Stiffness, Endothelial Function, Clinical and Laboratory Variables | Biotech Hunter | Biotech Hunter